Sareum Interim Loss Deepens On Costs As Pipeline Continues Progress
LONDON (Alliance News) - Cancer drug discovery firm Sareum Holdings PLC said Monday its interim loss widened as costs rose, but it made progress with its key developmental programmes.For to Read More